BIM
GNCA

BlackRock Investment Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

BlackRock Investment Management’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$18K Hold
532
– – ﹤0.01% 3422
2016
Q3 		$22K Hold
532
– – ﹤0.01% 3354
2016
Q2 		$17K Sell
532
-8,735
-94% -$320K ﹤0.01% 3436
2016
Q1 		$574K Buy
9,267
+210
+2% +$6.67K ﹤0.01% 2836
2015
Q4 		$382K Buy
9,057
+143
+2% +$6.82K ﹤0.01% 3090
2015
Q3 		$488K Buy
8,914
+855
+11% +$84.8K ﹤0.01% 3037
2015
Q2 		$885K Buy
8,059
+5,988
+289% +$556K ﹤0.01% 2863
2015
Q1 		$197K Buy
2,071
+582
+39% +$41.1K ﹤0.01% 3227
2014
Q4 		$83K Hold
1,489
– – ﹤0.01% 3338
2014
Q3 		$108K Sell
1,489
-3
-0.2% -$329 ﹤0.01% 3295
2014
Q2 		$224K Buy
1,492
+287
+24% +$43.5K ﹤0.01% 3225
2014
Q1 		$175K Buy
+1,205
New +$148K ﹤0.01% 3248

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

BlackRock Investment Management's GNCA Position: Q4 2016 in Review

BlackRock Investment Management held its Genocea Biosciences, Inc. (GNCA) position steady in Q4 2016 at 532 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #3422.

BlackRock Investment Management first reported a position in GNCA in Q1 2014 and has held it in 12 quarters since. The position peaked at $885K in Q2 2015. 47 funds tracked by Wall St. Rank hold GNCA as of Q4 2016.

  • BlackRock Investment Management held 532 shares of Genocea Biosciences, Inc. worth $18K as of Q4 2016.
  • BlackRock Investment Management left its Genocea Biosciences, Inc. share count unchanged in Q4 2016.
  • Genocea Biosciences, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3422 holding.
  • BlackRock Investment Management first reported a position in Genocea Biosciences, Inc. in Q1 2014 and has held it in 12 quarters since.
  • BlackRock Investment Management's Genocea Biosciences, Inc. position peaked at $885K in Q2 2015.
  • 47 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.